Contact: Renee Gaudette renee.gaudette@yale.edu
For Immediate Release: July 16, 2012
Daniel Petrylak, MD Named Leader of Prostate Medical Oncology at Yale Cancer Center
New Haven, Conn. —Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven have appointed Daniel P. Petrylak, MD, an internationally known medical oncologist, to lead the genitourinary cancers medical oncology team at Smilow Cancer Hospital and as director of the prostate cancer research group and co-director of the Signal Transduction Research Program. Dr. Petrylak joins Yale from NewYork-Presbyterian Hospital/Columbia University Medical Center. He will begin his new appointment on September 1, 2012.
“Dr. Petrylak’s national leadership on clinical trials for men with prostate and bladder cancer and his ability to consistently push for innovative therapies for his patients will strengthen the Prostate and Genitourinary Cancers Program at Smilow Cancer Hospital,” said Roy S. Herbst, MD, PhD, Chief of Medical Oncology and Associate Director for Translational Research at Yale Cancer Center and Smilow Cancer Hospital.
Currently, Dr. Petrylak is a Professor of Medicine at New York Presbyterian/Columbia Medical Center in New York. He is a member of the American Association for Cancer Research, American Society for Clinical Oncology, American College of Physicians, American Association for the Advancement of Science, American Urological Association, and the Southwest Oncology Group. Dr. Petrylak currently serves as the Principal Investigator or co-Principal Investigator on 7 Southwest Oncology Group (SWOG) clinical trials for genitourinary cancers. He also heads the advanced bladder cancer subcommittee for SWOG.
Dr. Petrylak received his undergraduate degree from Columbia College and his medical degree from Case Western University School of Medicine. He completed his internship and residency at Albert Einstein College of Medicine and his fellowship in medical oncology at Memorial Sloan-Kettering Cancer Center. He has authored more than 100 peer-reviewed articles and book chapters on prostate and bladder cancer research outcomes.
Yale Cancer Center is one of a select network of 41 comprehensive cancer centers in the country designated by the National Cancer Institute and the only one in Southern New England. Bringing together the resources of Smilow Cancer Hospital at Yale-New Haven and Yale School of Medicine, its mission encompasses patient care, research, cancer prevention and control, community outreach and education.
###